February 8, 2016
The Centers for Medicare and Medicaid Services’ billing code system for biosimilars earned it a “D-” grade at the House Energy and Commerce Health Subcommittee’s February 4 hearing on biologics.
February 4, 2016
In a November 2015 notice the Centers for Medicare and Medicaid Services warned that states rationing costly hepatitis C cures may “unreasonably restrict access” for Medicaid patients.
February 2, 2016
A tool designed to deliver cost-effective, quality cancer care needs reform, announced the American Society of Clinical Oncology (ASCO) in a January policy statement.
January 28, 2016
After years of international debate, the World Health Organization has issued its final proposal embracing distinct names for biological medicines, including biosimilars.
January 28, 2016
January 26 ended the public comment period for the U.S. Senate Finance Committee’s chronic care working group policy options paper—cueing the group’s legislative efforts to begin in earnest.
January 26, 2016
The U.S. Preventive Services Task Force has issued final guidance on how often and at what age women should receive mammograms to screen for breast cancer.
January 21, 2016
It’s time for clarity about the prescribing information that accompanies biosimilar medications, the U.S. House Doctors Caucus told the FDA in a Dec. 21, 2015 letter.
January 19, 2016
Patients diagnosed with debilitating conditions often struggle to pay the high deductibles required for their health plans to begin covering treatment. Now, a product designed by insurers to fill the gap for these patients is on the rise.
January 14, 2016
A safer, more comprehensive approach to managing pain before, during and after surgery exists – yet not all patients can access it.
January 12, 2016
The new year brings tighter laws on childhood vaccinations in several states—many spurred by California’s 2015 measles outbreak and the nationwide public health debate that followed.
